CME 
JOBS 
OUTBREAKS 
PEER-TO-PEER 
QUIZZES & QUESTIONS 
MEDTECH Despite the array of intensive treatment approaches, local control and overall survival rates in patients with advanced-stage disease remain low (approximately 40%–50% at 5 years). This review discusses recent studies integrating ICIs into definitive treatment regimens.
Peer-influenced content. Sources you trust. No registration required. This is HCN.
